首页 > 最新文献

Burns最新文献

英文 中文
Comments on: "Establishing new education standards in burns – A scoping review" 评论:“建立新的烧伤教育标准-范围审查”
IF 2.9 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2025-11-25 DOI: 10.1016/j.burns.2025.107810
M. Vijayasimha , Rajesh Prasad Jayaswal
{"title":"Comments on: \"Establishing new education standards in burns – A scoping review\"","authors":"M. Vijayasimha , Rajesh Prasad Jayaswal","doi":"10.1016/j.burns.2025.107810","DOIUrl":"10.1016/j.burns.2025.107810","url":null,"abstract":"","PeriodicalId":50717,"journal":{"name":"Burns","volume":"52 1","pages":"Article 107810"},"PeriodicalIF":2.9,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145736245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on: "Use of selective decontamination of the digestive tract in burn patients – A European survey" 评论:《选择性消化道消毒在烧伤患者中的应用——一项欧洲调查》
IF 2.9 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2025-11-25 DOI: 10.1016/j.burns.2025.107809
Wenqi Lv, Xiaoyan Yan
{"title":"Comment on: \"Use of selective decontamination of the digestive tract in burn patients – A European survey\"","authors":"Wenqi Lv, Xiaoyan Yan","doi":"10.1016/j.burns.2025.107809","DOIUrl":"10.1016/j.burns.2025.107809","url":null,"abstract":"","PeriodicalId":50717,"journal":{"name":"Burns","volume":"52 1","pages":"Article 107809"},"PeriodicalIF":2.9,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145736162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the effect of post-burn pruritus on patients' quality of life and experiences 烧伤后瘙痒对患者生活质量和体验的影响评价
IF 2.9 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2025-11-24 DOI: 10.1016/j.burns.2025.107808
Handan Aktas , Zahide Tuncbilek , Seyhan Hidiroğlu

Objective

The study aims to determine the experiences of patients who suffer from post-burn pruritus and to evaluate the effect of pruritus on their quality of life.

Method

The research employed a mixed-methods approach, combining both quantitative and qualitative methods. The study was carried out at the burn center of a city hospital in Istanbul. Individuals aged 18 and over who suffered burns after April 15, 2019, and continued to experience pruritus complaints were included in the study. A total of 120 patients were included in the quantitative phase of the study. Data for the quantitative phase were collected using the Patient Information Form, the Pruritus Information Collection Form, the 12-Item Pruritus Severity Scale, and the Burn-Specific Health Scale between July 2019 and March 2020. The qualitative phase was conducted between August 2019 and February 2020, concurrently with the collection of quantitative data. In the qualitative phase, in-depth face-to-face interviews were carried out with 11 individuals using a Semi-Structured Interview Form.

Results

It was determined that the patients experienced pruritus ranging from mild to severe (3.00–19.00), with the average pruritus score indicating moderate severity (8.91 ± 3.90). Significant differences were found between groups in terms of pruritus severity based on length of hospital stay, depth of burn, total body surface area burned, burned body region, and the presence of grafts (p < 0.05). In the in-depth interviews, it was found that burn patients struggled to cope with pruritus, that pruritus had an impact on their daily and family lives, and that it had physical, social, and psychological effects. Additionally, patients reported experiences related to the treatment of pruritus.

Conclusion

This study demonstrated that as the severity, distribution, and persistence of pruritus increased, it was perceived by patients as an unbearable symptom; and that pruritus is a significant factor reducing the quality of life in burn patients. It is suggested that the proper evaluation of pruritus using objective measurement tools, the development of appropriate protocols for the treatment and follow-up of post-burn pruritus, and providing education and counseling services to help burn patients cope with pruritus could improve the quality of life for burn patients experiencing pruritus.
目的了解烧伤后瘙痒患者的经历,评价瘙痒对患者生活质量的影响。方法采用定量与定性相结合的混合方法。这项研究是在伊斯坦布尔一家城市医院的烧伤中心进行的。在2019年4月15日之后遭受烧伤并继续出现瘙痒症状的18岁及以上的个体被纳入研究。共有120名患者被纳入定量研究阶段。在2019年7月至2020年3月期间,使用患者信息表、瘙痒信息收集表、12项瘙痒严重程度量表和烧伤特异性健康量表收集定量阶段的数据。定性阶段在2019年8月至2020年2月期间进行,同时收集定量数据。在定性阶段,使用半结构化访谈表对11名个人进行了深入的面对面访谈。结果患者瘙痒程度从轻度到重度(3.00-19.00),平均瘙痒评分为中度(8.91 ± 3.90)。根据住院时间、烧伤深度、烧伤总体表面积、烧伤体表面积和移植物存在程度,组间瘙痒严重程度差异有统计学意义(p <; 0.05)。在深入访谈中,我们发现烧伤患者很难应对瘙痒症,瘙痒症对他们的日常和家庭生活产生了影响,并对身体、社会和心理产生了影响。此外,患者报告了与瘙痒治疗相关的经历。结论本研究表明,随着瘙痒的严重程度、分布和持续时间的增加,患者认为瘙痒是一种难以忍受的症状;瘙痒是降低烧伤患者生活质量的一个重要因素。建议使用客观的测量工具对瘙痒进行评估,制定合适的烧伤后瘙痒治疗和随访方案,并提供教育和咨询服务,帮助烧伤患者应对瘙痒,以提高烧伤患者的生活质量。
{"title":"Evaluation of the effect of post-burn pruritus on patients' quality of life and experiences","authors":"Handan Aktas ,&nbsp;Zahide Tuncbilek ,&nbsp;Seyhan Hidiroğlu","doi":"10.1016/j.burns.2025.107808","DOIUrl":"10.1016/j.burns.2025.107808","url":null,"abstract":"<div><h3>Objective</h3><div>The study aims to determine the experiences of patients who suffer from post-burn pruritus and to evaluate the effect of pruritus on their quality of life.</div></div><div><h3>Method</h3><div>The research employed a mixed-methods approach, combining both quantitative and qualitative methods. The study was carried out at the burn center of a city hospital in Istanbul. Individuals aged 18 and over who suffered burns after April 15, 2019, and continued to experience pruritus complaints were included in the study. A total of 120 patients were included in the quantitative phase of the study. Data for the quantitative phase were collected using the Patient Information Form, the Pruritus Information Collection Form, the 12-Item Pruritus Severity Scale, and the Burn-Specific Health Scale between July 2019 and March 2020. The qualitative phase was conducted between August 2019 and February 2020, concurrently with the collection of quantitative data. In the qualitative phase, in-depth face-to-face interviews were carried out with 11 individuals using a Semi-Structured Interview Form.</div></div><div><h3>Results</h3><div>It was determined that the patients experienced pruritus ranging from mild to severe (3.00–19.00), with the average pruritus score indicating moderate severity (8.91 ± 3.90). Significant differences were found between groups in terms of pruritus severity based on length of hospital stay, depth of burn, total body surface area burned, burned body region, and the presence of grafts (p &lt; 0.05). In the in-depth interviews, it was found that burn patients struggled to cope with pruritus, that pruritus had an impact on their daily and family lives, and that it had physical, social, and psychological effects. Additionally, patients reported experiences related to the treatment of pruritus.</div></div><div><h3>Conclusion</h3><div>This study demonstrated that as the severity, distribution, and persistence of pruritus increased, it was perceived by patients as an unbearable symptom; and that pruritus is a significant factor reducing the quality of life in burn patients. It is suggested that the proper evaluation of pruritus using objective measurement tools, the development of appropriate protocols for the treatment and follow-up of post-burn pruritus, and providing education and counseling services to help burn patients cope with pruritus could improve the quality of life for burn patients experiencing pruritus.</div></div>","PeriodicalId":50717,"journal":{"name":"Burns","volume":"52 1","pages":"Article 107808"},"PeriodicalIF":2.9,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145736244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BACH1 is stabilized by vitamin E and attenuates the formation of hypertrophic scar through the Wnt/β-catenin pathway BACH1被维生素E稳定,并通过Wnt/β-catenin途径减弱增生性瘢痕的形成
IF 2.9 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2025-11-22 DOI: 10.1016/j.burns.2025.107807
Wenkang Luan , Shujun Fan , Hanyi Jiang , Dongwen Jiang , Jinxiu Yang , Leren He
The molecular drivers behind the pathogenesis of hypertrophic scar (HS) formation have not been determined in a comprehensive manner. Aside from that, no consensus has been reached on the role of vitamin E in HS. For this reason, we have probed the causal effect of 2940 plasma proteins and 187 diets on HS through Mendelian randomization (MR). Colocalization analysis, summary-data-based MR (SMR), heterogeneity in dependent instruments (HEIDI), and MR phenome-wide association study (MR-PheWAS) were employed to identify the potential drug targets of HS. Human Protein Atlas, differential expression analysis, weighted co-expression network analysis (WGCNA) and single-cell analysis were utilized to confirm the key biomolecules in HS. To investigate the roles of critical molecules, we harvested primary fibroblasts and conducted validations using both in vitro and in vivo animal models. We put forth a viewpoint that the transcription factor BACH1 is causally related to the onset of HS, is a protective factor for HS, and may serve as its therapeutic target. We further determined that BACH1 reveals substantial expression in human skin tissue. BACH1 is under-expressed in HS tissues and fibroblasts. We confirmed that BACH1 and vitamin E act in an anti-scar role in primary fibroblasts and animal models through the Wnt/β-catenin pathway. Overall, our results demonstrate that BACH1 has an inhibitory effect on HS, and vitamin E attenuates the formation of HS by stabilizing BACH1.
增生性瘢痕(HS)形成的分子驱动机制尚未全面确定。除此之外,关于维生素E在HS中的作用还没有达成共识。为此,我们通过孟德尔随机化(Mendelian randomization, MR)研究了2940种血浆蛋白和187种日粮对HS的因果关系。采用共定位分析、基于汇总数据的MR (SMR)、依赖工具异质性(HEIDI)和MR全现象关联研究(MR- phewas)来确定HS的潜在药物靶点。利用人蛋白图谱、差异表达分析、加权共表达网络分析(WGCNA)和单细胞分析确定HS的关键生物分子。为了研究关键分子的作用,我们收集了原代成纤维细胞,并在体外和体内动物模型中进行了验证。我们认为转录因子BACH1与HS的发病有因果关系,是HS的保护因子,可能是HS的治疗靶点。我们进一步确定BACH1在人体皮肤组织中大量表达。BACH1在HS组织和成纤维细胞中表达不足。我们证实BACH1和维生素E通过Wnt/β-catenin途径在原代成纤维细胞和动物模型中发挥抗疤痕作用。综上所述,我们的研究结果表明BACH1对HS具有抑制作用,维生素E通过稳定BACH1来减弱HS的形成。
{"title":"BACH1 is stabilized by vitamin E and attenuates the formation of hypertrophic scar through the Wnt/β-catenin pathway","authors":"Wenkang Luan ,&nbsp;Shujun Fan ,&nbsp;Hanyi Jiang ,&nbsp;Dongwen Jiang ,&nbsp;Jinxiu Yang ,&nbsp;Leren He","doi":"10.1016/j.burns.2025.107807","DOIUrl":"10.1016/j.burns.2025.107807","url":null,"abstract":"<div><div>The molecular drivers behind the pathogenesis of hypertrophic scar (HS) formation have not been determined in a comprehensive manner. Aside from that, no consensus has been reached on the role of vitamin E in HS. For this reason, we have probed the causal effect of 2940 plasma proteins and 187 diets on HS through Mendelian randomization (MR). Colocalization analysis, summary-data-based MR (SMR), heterogeneity in dependent instruments (HEIDI), and MR phenome-wide association study (MR-PheWAS) were employed to identify the potential drug targets of HS. Human Protein Atlas, differential expression analysis, weighted co-expression network analysis (WGCNA) and single-cell analysis were utilized to confirm the key biomolecules in HS. To investigate the roles of critical molecules, we harvested primary fibroblasts and conducted validations using both in vitro and in vivo animal models. We put forth a viewpoint that the transcription factor BACH1 is causally related to the onset of HS, is a protective factor for HS, and may serve as its therapeutic target. We further determined that BACH1 reveals substantial expression in human skin tissue. BACH1 is under-expressed in HS tissues and fibroblasts. We confirmed that BACH1 and vitamin E act in an anti-scar role in primary fibroblasts and animal models through the Wnt/β-catenin pathway. Overall, our results demonstrate that BACH1 has an inhibitory effect on HS, and vitamin E attenuates the formation of HS by stabilizing BACH1.</div></div>","PeriodicalId":50717,"journal":{"name":"Burns","volume":"52 1","pages":"Article 107807"},"PeriodicalIF":2.9,"publicationDate":"2025-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145736243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comments on: "Admission lymphopenia predicts risk of pneumonia and AKI in hospitalized burn injuries" 评论:“入院时淋巴细胞减少可预测住院烧伤患者肺炎和AKI的风险”
IF 2.9 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2025-11-21 DOI: 10.1016/j.burns.2025.107806
Min Zhang , Xingyi Yang
{"title":"Comments on: \"Admission lymphopenia predicts risk of pneumonia and AKI in hospitalized burn injuries\"","authors":"Min Zhang ,&nbsp;Xingyi Yang","doi":"10.1016/j.burns.2025.107806","DOIUrl":"10.1016/j.burns.2025.107806","url":null,"abstract":"","PeriodicalId":50717,"journal":{"name":"Burns","volume":"52 1","pages":"Article 107806"},"PeriodicalIF":2.9,"publicationDate":"2025-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145614204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comments on: "Burn injury in obesity: Examination of the Burn Care Quality Platform’s (BCQP) available data on obese patients to determine burn-related outcomes" 评论:“肥胖烧伤:检查烧伤护理质量平台(BCQP)对肥胖患者的可用数据,以确定烧伤相关结局”
IF 2.9 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2025-11-20 DOI: 10.1016/j.burns.2025.107801
Mahta Moghaddam Ahmadi, Moein Moghaddam Ahmadi
{"title":"Comments on: \"Burn injury in obesity: Examination of the Burn Care Quality Platform’s (BCQP) available data on obese patients to determine burn-related outcomes\"","authors":"Mahta Moghaddam Ahmadi,&nbsp;Moein Moghaddam Ahmadi","doi":"10.1016/j.burns.2025.107801","DOIUrl":"10.1016/j.burns.2025.107801","url":null,"abstract":"","PeriodicalId":50717,"journal":{"name":"Burns","volume":"52 1","pages":"Article 107801"},"PeriodicalIF":2.9,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145617716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term skin quality and scar formation after enzymatic debridement of deep-dermal burn wounds: A follow-up comparative study of Suprathel® and Jelonet® 深皮烧伤创面酶清创后的长期皮肤质量和瘢痕形成:superthel®和Jelonet®的随访比较研究
IF 2.9 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2025-11-20 DOI: 10.1016/j.burns.2025.107803
Wolfram Heitzmann , Mitja Mossing , Maria von Kohout , Yasser Alhujaili , Jan Akkan , Paul Christian Fuchs , Rolf Lefering , Jennifer Lynn Schiefer
Recent advances in burn care have highlighted the benefits of enzymatic debridement in reducing long-term scarring by preserving viable dermal structures. Nexobrid®, a bromelain-based enzymatic debridement agent, has become an established treatment modality for deep-dermal burns, particularly of the hand, due to its selective action and tissue-sparing properties. After debridement, the choice of dressing critically influences inflammation, re-epithelialization, and ultimately scar quality and skin function. In clinical practice, Suprathel®, a synthetic copolymer membrane, and Jelonet®, a paraffin-impregnated gauze, are widely used. While Suprathel® offers improved pain control and patient comfort, Jelonet® remains a cost-effective standard.
Building on our previous intra-individual trial, which showed similar healing times but greater patient comfort with Suprathel®, this planned single-center, prospective long-term follow-up aims to address the lack of data on long-term scar quality and skin barrier function after enzymatic debridement. It includes the same 23 patients with deep-dermal hand burns who had received wound coverage with both Suprathel® and Jelonet® on comparable wound areas, assessed at 3, 6, and 12 months using objective instruments (Cutometer®, Mexameter®, Tewameter®, O2C®) and subjective scales (Vancouver Scar Scale, Patient and Observer Scar Assessment Scale).
Both dressings resulted in favorable and largely comparable scar outcomes over 12 months, with no significant differences in elasticity, perfusion, or overall clinical scar appearance. Subtle yet statistically significant differences in transepidermal water loss (p < 0.01) and pigmentation (p < 0.01) indicated a trend toward enhanced epidermal barrier restoration and reduced hypopigmentation in Suprathel®-treated areas, although these effects did not translate into perceptible clinical advantages.
These results confirm that both Suprathel® and Jelonet® are effective options for post-enzymatic debridement wound coverage, showing comparable long-term scar outcomes. The choice may reasonably depend on clinical workflow and dressing-management preferences, with Suprathel® remaining the standard in our burn center due to its reduced frequency of dressing changes.
烧伤护理的最新进展强调了酶清创的好处,通过保留可行的皮肤结构来减少长期疤痕。Nexobrid®是一种以菠萝蛋白酶为基础的酶清创剂,由于其选择性作用和组织保护特性,已成为深层皮肤烧伤,特别是手部烧伤的一种成熟的治疗方式。清创后,敷料的选择严重影响炎症、上皮再生,最终影响疤痕质量和皮肤功能。在临床实践中,Suprathel®是一种合成共聚物膜,Jelonet®是一种石蜡浸渍纱布,被广泛使用。虽然Suprathel®提供改善的疼痛控制和患者舒适度,但Jelonet®仍然是一个具有成本效益的标准。在我们之前的个体内试验的基础上,Suprathel®显示了相似的愈合时间,但患者更舒适,这项计划的单中心前瞻性长期随访旨在解决酶清创后长期疤痕质量和皮肤屏障功能数据的缺乏。它包括同样的23例手部深层烧伤患者,他们在类似的伤口面积上接受了Suprathel®和Jelonet®的伤口覆盖,在3、6和12个月时使用客观仪器(Cutometer®,meexameter®,Tewameter®,O2C®)和主观量表(温哥华疤痕量表,患者和观察者疤痕评估量表)进行评估。两种敷料在12个月的时间里都产生了良好的疤痕结果,并且在很大程度上是相似的,在弹性、灌注或总体临床疤痕外观方面没有显著差异。经皮失水(p <; 0.01)和色素沉着(p <; 0.01)的细微但有统计学意义的差异表明,在Suprathel®治疗区域,表皮屏障恢复增强和色素沉着减少的趋势,尽管这些效果并没有转化为可察觉的临床优势。这些结果证实Suprathel®和Jelonet®都是酶清创后伤口覆盖的有效选择,显示出可比的长期疤痕结局。选择可能合理地取决于临床工作流程和敷料管理偏好,由于其减少了敷料更换的频率,superthel®仍然是我们烧伤中心的标准。
{"title":"Long-term skin quality and scar formation after enzymatic debridement of deep-dermal burn wounds: A follow-up comparative study of Suprathel® and Jelonet®","authors":"Wolfram Heitzmann ,&nbsp;Mitja Mossing ,&nbsp;Maria von Kohout ,&nbsp;Yasser Alhujaili ,&nbsp;Jan Akkan ,&nbsp;Paul Christian Fuchs ,&nbsp;Rolf Lefering ,&nbsp;Jennifer Lynn Schiefer","doi":"10.1016/j.burns.2025.107803","DOIUrl":"10.1016/j.burns.2025.107803","url":null,"abstract":"<div><div>Recent advances in burn care have highlighted the benefits of enzymatic debridement in reducing long-term scarring by preserving viable dermal structures. Nexobrid®, a bromelain-based enzymatic debridement agent, has become an established treatment modality for deep-dermal burns, particularly of the hand, due to its selective action and tissue-sparing properties. After debridement, the choice of dressing critically influences inflammation, re-epithelialization, and ultimately scar quality and skin function. In clinical practice, Suprathel®, a synthetic copolymer membrane, and Jelonet®, a paraffin-impregnated gauze, are widely used. While Suprathel® offers improved pain control and patient comfort, Jelonet® remains a cost-effective standard.</div><div>Building on our previous intra-individual trial, which showed similar healing times but greater patient comfort with Suprathel®, this planned single-center, prospective long-term follow-up aims to address the lack of data on long-term scar quality and skin barrier function after enzymatic debridement. It includes the same 23 patients with deep-dermal hand burns who had received wound coverage with both Suprathel® and Jelonet® on comparable wound areas, assessed at 3, 6, and 12 months using objective instruments (Cutometer®, Mexameter®, Tewameter®, O2C®) and subjective scales (Vancouver Scar Scale, Patient and Observer Scar Assessment Scale).</div><div>Both dressings resulted in favorable and largely comparable scar outcomes over 12 months, with no significant differences in elasticity, perfusion, or overall clinical scar appearance. Subtle yet statistically significant differences in transepidermal water loss (p &lt; 0.01) and pigmentation (p &lt; 0.01) indicated a trend toward enhanced epidermal barrier restoration and reduced hypopigmentation in Suprathel®-treated areas, although these effects did not translate into perceptible clinical advantages.</div><div>These results confirm that both Suprathel® and Jelonet® are effective options for post-enzymatic debridement wound coverage, showing comparable long-term scar outcomes. The choice may reasonably depend on clinical workflow and dressing-management preferences, with Suprathel® remaining the standard in our burn center due to its reduced frequency of dressing changes.</div></div>","PeriodicalId":50717,"journal":{"name":"Burns","volume":"52 1","pages":"Article 107803"},"PeriodicalIF":2.9,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145571730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology of emergency department visits for burn injuries in the United States, 2014–2023 2014-2023年美国烧伤急诊就诊流行病学
IF 2.9 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2025-11-20 DOI: 10.1016/j.burns.2025.107802
Nicholas D. Soulakis , Caroline Hensing , Annabelle Shaffer , David Gonzalez-Velez , Ashley A. Peters , Nathan Pecoraro , Paul M. Arnold

Introduction

Burn injuries cause significant morbidity and mortality. By better understanding the epidemiology and seasonality of such injuries, burn education and prevention efforts can be improved. The purpose of this investigation is to provide an update to the epidemiology of burn injuries in the United States (US).

Methods

This retrospective study analyzes data from the National Electronic Injury Surveillance System (NEISS) from 2014 to 2023. The NEISS collects data on emergency department visits from approximately 100 hospitals throughout the US. Data were analyzed using R version 4.4.3. to calculate annual burn estimates, injury rates, frequencies and acute periods of increased incidence.

Results

Between 2014 and 2023, emergency departments in the US treated an average of 206,856 burn injuries annually. These injuries occurred mainly in the home (66.8 %) and in males (53.1 %), with a peak incidence in children under 5 (20.6 %). This study found no significant increasing or decreasing trends in incidence over time; however, burn injury incidence and associated products fluctuated based on season, with an increased incidence occurring around July 4th.

Conclusion

Burn injuries significantly affect the US population. Public health and primary care workers may utilize information provided by this study to better target patient education on burn injury prevention.
烧伤引起严重的发病率和死亡率。通过更好地了解这类损伤的流行病学和季节性,可以改进烧伤教育和预防工作。本研究的目的是提供美国烧伤流行病学的最新情况。方法回顾性分析2014 - 2023年美国国家电子伤害监测系统(NEISS)的数据。NEISS收集了美国大约100家医院急诊就诊的数据。数据分析使用R 4.4.3版本。计算年度烧伤估计,损伤率,频率和急性期增加的发生率。结果2014年至2023年间,美国急诊部门平均每年治疗206856例烧伤。这些伤害主要发生在家中(66.8% %)和男性(53.1% %),5岁以下儿童发病率最高(20.6% %)。这项研究没有发现发病率随时间增加或减少的显著趋势;然而,烧伤发生率和相关产物随季节而波动,7月4日前后发生率增加。结论烧伤对美国人群影响显著。公共卫生和初级保健工作者可以利用本研究提供的信息,更好地针对患者进行烧伤预防教育。
{"title":"Epidemiology of emergency department visits for burn injuries in the United States, 2014–2023","authors":"Nicholas D. Soulakis ,&nbsp;Caroline Hensing ,&nbsp;Annabelle Shaffer ,&nbsp;David Gonzalez-Velez ,&nbsp;Ashley A. Peters ,&nbsp;Nathan Pecoraro ,&nbsp;Paul M. Arnold","doi":"10.1016/j.burns.2025.107802","DOIUrl":"10.1016/j.burns.2025.107802","url":null,"abstract":"<div><h3>Introduction</h3><div>Burn injuries cause significant morbidity and mortality. By better understanding the epidemiology and seasonality of such injuries, burn education and prevention efforts can be improved. The purpose of this investigation is to provide an update to the epidemiology of burn injuries in the United States (US).</div></div><div><h3>Methods</h3><div>This retrospective study analyzes data from the National Electronic Injury Surveillance System (NEISS) from 2014 to 2023. The NEISS collects data on emergency department visits from approximately 100 hospitals throughout the US. Data were analyzed using R version 4.4.3. to calculate annual burn estimates, injury rates, frequencies and acute periods of increased incidence.</div></div><div><h3>Results</h3><div>Between 2014 and 2023, emergency departments in the US treated an average of 206,856 burn injuries annually. These injuries occurred mainly in the home (66.8 %) and in males (53.1 %), with a peak incidence in children under 5 (20.6 %). This study found no significant increasing or decreasing trends in incidence over time; however, burn injury incidence and associated products fluctuated based on season, with an increased incidence occurring around July 4th.</div></div><div><h3>Conclusion</h3><div>Burn injuries significantly affect the US population. Public health and primary care workers may utilize information provided by this study to better target patient education on burn injury prevention.</div></div>","PeriodicalId":50717,"journal":{"name":"Burns","volume":"52 1","pages":"Article 107802"},"PeriodicalIF":2.9,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145736253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comments on: "Background pain, procedural pain, and optimism are associated with post-discharge pain in burn survivors" 评论:“背景疼痛、程序性疼痛和乐观情绪与烧伤幸存者出院后疼痛有关”
IF 2.9 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2025-11-19 DOI: 10.1016/j.burns.2025.107799
Shujun Qiu, Mingxian Chen
{"title":"Comments on: \"Background pain, procedural pain, and optimism are associated with post-discharge pain in burn survivors\"","authors":"Shujun Qiu,&nbsp;Mingxian Chen","doi":"10.1016/j.burns.2025.107799","DOIUrl":"10.1016/j.burns.2025.107799","url":null,"abstract":"","PeriodicalId":50717,"journal":{"name":"Burns","volume":"52 1","pages":"Article 107799"},"PeriodicalIF":2.9,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145736246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Historical note: The research strategy that halved postburn mortality 历史注释:研究策略使烧伤后死亡率减半
IF 2.9 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2025-11-19 DOI: 10.1016/j.burns.2025.107781
Leopoldo C. Cancio, Kaitlin A. Pruskowski
{"title":"Historical note: The research strategy that halved postburn mortality","authors":"Leopoldo C. Cancio,&nbsp;Kaitlin A. Pruskowski","doi":"10.1016/j.burns.2025.107781","DOIUrl":"10.1016/j.burns.2025.107781","url":null,"abstract":"","PeriodicalId":50717,"journal":{"name":"Burns","volume":"52 1","pages":"Article 107781"},"PeriodicalIF":2.9,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145614203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Burns
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1